Patent Number: 8,815,936

Title: Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders

Abstract: Described is a composition for preventing or treating an oxidative stress related disease or condition in a subject. The disease or condition is characterized by the presence of excess oxidative compounds in the subject, and the composition includes a synergistic combination of therapeutically effective amounts of resveratrol to promote NAD.sup.+ synthesis in the subject; a chelating agent to reduce production of additional oxidative compounds in the subject; and an antioxidant to minimize the oxidative activity in the subject.

Inventors: Grant; Ross Stewart (Kellyville, AU), Braidy; Nady (Riverwood, AU), Guillemin; Gilles (Mount Colah, AU), Smythe; George (Leichhardt, AU)

Assignee: Nad Life Pty Ltd

International Classification: A01N 43/38 (20060101); A01N 43/16 (20060101); A01N 43/08 (20060101); A01N 31/04 (20060101); A01N 37/00 (20060101); C07C 39/12 (20060101)

Expiration Date: 8/26/12018